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Introduction
People living with HIV (PLHIV) are disproportionately 
affected by depression. Within high HIV prevalence settings, 
such as sub-Saharan Africa, the prevalence of  depression 
symptoms ranges from 18% to 80% among PLHIV, which 
is notably higher than the depression symptoms prevalence 
among the general population1. Depression among PLHIV 
is strongly and consistently associated with reduced 
antiretroviral therapy (ART) adherence1,2. Depression can 
also lead to high-risk sexual behaviors that ultimately may 
increase the likelihood of  HIV transmission to uninfected 
partners3-5. To improve treatment outcomes and prevent 
ongoing transmission, depression must be diagnosed among 
PLHIV for optimal engagement in HIV care and treatment.
The intrinsic relationship between depression and HIV is 
complex with adverse effects on HIV care and treatment 
engagement. Depression can precede HIV acquisition or can 
be a consequence of  HIV infection. After an HIV diagnosis, 
underlying depression can worsen or be induced by infection 
awareness2,7. In many settings globally, PLHIV who have 
depression have suboptimal engagement and retention in 
care and poor antiretroviral adherence, which as a result, 
leads to poor clinical outcomes8-14.
Although it is well-established that depression leads to poor 
HIV outcomes, depression is often undetected and untreated 
among PLHIV. Particularly within sub-Saharan Africa, 
limited skilled mental health professionals are overburdened 
and mental health services for PLHIV are scarce7,15,16. 
In Malawi, where the HIV prevalence is approximately 
9% among women and men aged 15-49 years, there is a 
severe lack of  trained mental health care professionals 
and a knowledge gap of  current prevalence and correlates 
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Background
Depression and suicide ideation among people living with HIV (PLHIV) can threaten the success of  HIV care and treatment programs, 
particularly within high HIV prevalence settings.  We describe the prevalence and correlates associated with depression and suicidal 
ideation among PLHIV receiving HIV care in Lilongwe, Malawi.  
Methods
From July to September 2013, 206 HIV clinic patients, who were ≥18 years of  age and either pre-antiretroviral therapy (ART) or 
established on ART for ≥6 months prior to study, participated in a survey to assess the prevalence of  a likely depressive disorder and 
suicidal ideation using the Patient Health Questionnaire-9.  We explored factors associated with depression using bivariable linear 
regression and suicidal ideation using bivariable log-binomial regression.  
Results
The prevalence of  a likely depressive disorder and suicidal ideation was 12% (95% CI: 8%, 17%) and 16% (95% CI: 11%, 21%), 
respectively.  Pre-ART patients (β=1.17, 95% CI: 0.03, 2.30, p-value=0.04) and those with problematic alcohol use (β=0.49, 95% CI: 
0.07, 0.92, p-value=0.02) were associated with a higher depression severity.  Suicidal ideation was relatively common (8%, 95% CI: 
5%, 13%) among those without a likely depressive disorder and significantly correlated with having no primary, secondary, or tertiary 
education (β=-1.52, 95% CI: -2.46, -0.59, p-value<0.01).  
Conclusions
Interventions that enhance identification and management of  depressive disorders and suicidal ideation should be integrated within HIV 
care clinics in Malawi.
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of  depression among PLHIV accessing treatment17,18. 
Those with depression are also at greater risk for suicidal 
ideation19,20.  However, few have examined suicidal ideation 
among PLHIV in high HIV prevalent settings, such as sub-
Saharan Africa21,22. Without a proper understanding of  the 
relationships between depression, including suicidal ideation, 
ART, and other factors in sub-Saharan African settings, it 
will be difficult to know how best to direct scarce resources.
Given the limited literature on depression and especially, 
suicidal ideation among PLHIV, the primary purpose for 
this formative study was to inform future, prospective, 
appropriately-powered studies on depression and suicidal 
ideation among PLHIV in Malawi. We assessed the prevalence 
of  depression and suicidal ideation and explored factors 
associated with depression and suicidal ideation among 
people living with HIV, including pre-ART and established 
ART patients, receiving HIV care in Lilongwe, Malawi. 
Methods 
Study design and population
We conducted a descriptive, cross-sectional study from July 
to September 2013 in Lighthouse Trust, an HIV prevention, 
treatment and care clinic located in Lilongwe, Malawi. The 
Lighthouse Trust clinic provides HIV testing and counseling, 
HIV primary care, management of  opportunistic infections, 
ART care, cervical cancer screening, and family planning 
for all people living with HIV, in addition to conducting 
operations research. To systematically identify participants, 
we selected every third patient visiting the Lighthouse Trust 
clinic to assess eligibility for participation. Inclusion criteria 
were at least 18 years of  age, men and women living with 
HIV who registered and receiving care from Lighthouse 
Trust clinic, either pre-ART or on established ART for at 
least 6 months prior to study participation, and willing and 
able to provide informed consent. Exclusion criteria were 
less than 18 years of  age, reported use of  psychiatric drugs, 
on ART for less than 6 months prior to study participation, 
or possessing cognitive impairment or physical limitations 
that would prevent participation. 
Participants found to be depressed with a score of  10 or 
higher on the Patient Health Questionnaire-9 (PHQ-9)23 
were referred to Bwaila Mental Hospital for additional care 
and those experiencing acute suicidal ideation were referred 
for immediate assistance and care. 
Data collection
Participants who provided informed consent received an 
interviewer-administered structured questionnaire to collect 
detailed information on demographics, HIV care, ART 
history, social and sexual behavior, alcohol use, suicidal 
ideation, and depression. The questionnaire was translated and 
back-translated from English to Chichewa, the predominant 
language in Malawi. Both English and Chichewa versions of  
the questionnaire were available to participants. To determine 
the prevalence of  depression, we used the PHQ-9 to assess 
the presence of  the 9 core symptoms of  depression within 
the past two weeks as specified by the DMS-IV23. The PHQ-
9 has been internationally validated in several clinics within 
resource limited settings24-26. Scores range between 0 and 27, 
with a score of  10 or higher indicative of  the presence of  
a likely clinically significant depressive disorder.  Scores are 
also grouped by severity into the following categories: <5 no 
depression, 5-9 as mild depression (although not considered 
a depressive illness that would require treatment), 10-19 as 
moderate depression, and 20-27 as severe depression.  The 
PHQ-9 was developed to be self-administered, however, 
interview administration has yielded similar results27, and 
thus was used in this way in this study.
Suicidal ideation was assessed using question 9 on the PHQ-
9, which states “During the past two weeks how often have 
you had thoughts that you would be better off  dead or 
hurting yourself  in some way?” Responses included: “not at 
all, several days, more than half  the days, or nearly every day”. Any 
response other than “not at all” was considered experiencing 
suicidal ideation. 
Potential factors associated with depression were identified 
through a review of  the literature and included: sexual 
behaviours, such as more sexual partners in the last month, 
more sexual encounters in the last month by primary 
and casual partnership, higher number and proportion 
of  condom use in the last month by primary and casual 
partnership, increased alcohol use, measured using the 
Cutting down, Annoyance by criticism, Guilty feelings, and 
Eye-openers (CAGE) assessment (0=no risk; 1=at risk; 
2=current problem; 3=dependence), comorbidities with 
HIV (yes vs. no), HIV disclosure to at least one person 
(yes vs. no), and self-reported ART adherence (number of  
pills missed) 1,2,6,28,29. A parsimonious set of  potential factors 
associated with suicidal ideation included: ART use (pre-
ART vs established ART), marital status (married vs. not 
married), HIV disclosure to at least one person (yes vs. no), 
and education (no education vs. any primary, secondary, or 
tertiary)30-33.
Statistical analysis 
We describe patient characteristics and sexual behaviors by 
ART use with frequencies and proportions for categorical 
variables and means and standard deviations (SD) for 
continuous variables. We examined the prevalence of  
depression and suicidal ideation for the total population 
and compared those pre-ART vs. established ART using 
Pearson’s Chi-squared tests for categorical variables.  We used 
bivariable linear regression to explore factors associated with 
depression and bivariable log-binomial regression to explore 
an a priori set factors associated with suicidal ideation.  A 
p-value less than 0.05 was considered statistically significant 
statistical trends were noted. Data were analyzed using 
STATA version 12.0 software package.
Results 
Study cohort characteristics 
Of  the 223 patients sampled, 206 (92%) were eligible and 
provided informed consent.  Six patients (3%) were ineligible 
for participation and 11 (5%) declined participation in the 
study.  Of  the 206 paticipants who consented, 103 (50%) 
were pre-ART and 103 (50%) were established on ART. Of  
the 206 participants receiving HIV care, the mean age for this 
study population was 38 years (SD=10) and 59% (n=121) 
were female (Table 1).  Approximately 60% (n=129) were 
married and living with their partner.  Most had received 
primary education (46%; n=46) and were living in unburned 
brick housing structures (56%).  About one-third had running 
water (36%; n=74) or electricity in their home (32%; n=66). 
Nearly all had disclosed their HIV status (94%; n=193) to 
at least one person.  The mean number of  sexual partners 
in the past month was 1.21 (SD: 6.18). Using the CAGE 
assessment, 11% (n=23) were considered to have at-risk 
drinking (CAGE score=1), 18% (n=37) were considered to 
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Yes 37 (18%) 19 (18%) 18 (17%)
No 169 (82%) 84 (82%) 85 (83%)




1.21 (6.18) 1.7 (8.7) 0.70 (0.50)




Primary partner 5.66 (6.53) 6.41 (7.36) 4.92 (5.54)
Casual partner 16.64 (30.84) 20.64 (33.97) 2.00 (1.73)
Mean number of 
times using a 
condom, past 
month
Primary partner 4.25 (5.59) 4.52 (6.53) 3.98 (4.51)





Primary partner 0.72 (0.37) 0.64 (0.41) 0.79 (0.32)
Casual partner 0.84 (0.34) 0.80 (0.37) 1.00 (0.00)
Alcohol use
No risk, CAGE 
score=0 106 (51%) 36 (35%) 70 (68%)
At risk, CAGE 
score=1 23 (11%) 17 (17%) 6 (6%)
Current problem, 
CAGE score=2 37 (18%) 27 (26%) 10 (10%)
Dependence, 
CAGE score ≥3 40 (19%) 23 (22%) 17 (17%)
SD: Standard deviation; CAGE: Cutting down, Annoyance by 
criticism, Guilty feelings, and Eye-openers assessment
Prevalence and correlates of depression
The mean PHQ-9 score was 4 (SD=4). Overall, the prevalence 
of  a likely depressive disorder (PHQ-9 score ≥10) was 12% 
(95% CI: 8%, 17%) (Table 2). 23% of  all the participants had 
mild depression not severe enough to indicate the presence 
of  a depressive disorder (PHQ-9 score 5-9) or require specific 
treatment. 12% had moderate depression (PHQ score 10-19) 
and no participants reported severe depression (PHQ-9 score 
≥20). The prevalence of  depression was comparable across 
both those pre-ART and established on ART (16% vs. 9%, p 
value=0.24). Pre-ART patients had 1.17-point higher PHQ-
9 score (95% CI: 0.03, 2.30, p value= 0.04) when compared 
to established ART patients (Table 3).  Not being married 
(β= 0.32, 95% CI: -0.92, 1.57, p value=0.61) and having no 
primary, secondary, or tertiary education (β= -1.03, 95% CI: 
-2.64, 0.58, p value=0.21) were not significantly correlated 
with depression. 
have current problem drinking (CAGE score=2), and 19% 









Mean (SD) or n (%)
Age, mean 38 (10) 36 (9) 39 (11)
Gender
Male 84 (41%) 47 (46%) 37 (36%)
Female 121 (59%) 55 (53%) 66 (64%)
Marital status
Married living 
with partner 129 (63%) 57 (55%) 72 (70%)
Married living 
apart from partner 15 (7%) 10 (10%) 5 (5%)
Widowed 25 (12%) 12 (12%) 13 (13%)
Divorced/
separated 28 (14%) 20 (19%) 8 (8%)
Never married 9 (4%) 4 (4%) 5 (5%)
Education
None 30 (15%) 13 (13%) 17 (17%)
Primary 94 (46%) 47 (46%) 47 (46%)
Secondary 64 (31%) 34 (33%) 30 (29%)
Tertiary 18 (9%) 9 (9%) 9 (9%)
Housing type
Poles and grass 0 0 0
Unburned bricks 115 (56%) 60 (58%) 55 (53%)
Burnt bricks and 
mud 30 (15%) 15 (15%) 15 (15%)
Burnt bricks and 
cement 61 (30%) 28 (27%) 33 (32%)
Water in home
Yes 74 (36%) 38 (37%) 36 (35%)
No 132 (64%) 65 (63%) 67 (65%)
Electricity in home
Yes 66 (32%) 35 (34%) 31 (30%)
No 140 (68%) 68 (66%) 72 (70%)
HIV status 
disclosure
Yes 193 (94%) 90 (87%) 103 (100%)
No 13 (6%) 13 (13%) 0
ART adherence
Mean number 
of pills missed, 
past month




Yes 27 (13%) 13 (13%) 14 (14%)
No 179 (87%) 90 (87%) 89 (86%)
Table 1: Patient characteristics and sexual behaviors by ART use 
among people living with HIV receiving HIV care in Lilongwe, 
Malawi, July to September 2013; N=206















score <5 134 (65%) 62 (60%) 72 (70%)
Mild depression, 












Yes 32 (16%) 21 (20%) 11 (11%)
No 174 (84%) 82 (80%) 92 (89%)
PHQ-9: Patient Health Questionnaire
Coefficient 95% CI p-value
Marital status





-1.03 (-2.64, 0.58) 0.21
Any primary, 
secondary, or tertiary reference
ART use
     Pre-ART 1.17 (0.03, 2.30) 0.04
     Established ART reference
HIV status disclosure
Yes reference
No -0.19 (-2.54, 2.15) 0.87
ART adherence
Number of pills 




Yes 0.71 (-0.98, 2.40) 0.40
No reference
Living with an 
illness other than HIV
Yes 0.42 (-1.06, 1.91) 0.58
No reference




Number of sexual 
encounters, 
past month
Primary partner -0.07 (-0.17, 0.03) 0.15
Casual partner -0.01 (-0.11, 0.09) 0.80
Number of times using 
a condom, past month
Primary partner -0.10 (-0.22, 0.02) 0.11




Primary partner -0.65 (-2.41, 1.10) 0.46






More problematic alcohol use, as indicated by a higher 
CAGE score, was significantly correlated with depression, 
with a p value=0.02. Every one point increase on the CAGE 
was associated with a 0.49-point (95% CI: 0.07, 0.92) higher 
PHQ-9 score. The number of  times using a condom with 
both primary partners (β= -0.10, 95% CI: -0.22, 0.02, p 
value=0.11) and casual partners (β= -0.21, 95% CI: -0.21, 
0.03, p value=0.14) was associated with lower depression 
scores, although not statically significant.  There was little to 
no correlation between number of  missed pills and PHQ-
9 score for depression (β= -0.12, 95% CI: -0.57, 0.32, p 














Yes 32 (16%) 17 (68%) 15 (8%)
No 174 (84%) 8 (32%) 166 (92%)
Prevalence and correlates of suicidal ideation
The prevalence of  suicidal ideation among all the participants, 
independent of  depression status, was 16% (95% CI: 11%, 
21%) (Table 2). When compared to those established on 
ART, pre-ART participants were more likely to have suicidal 
ideation (20% versus 11%; p value=0.05). The suicidal 
ideation prevalence among those with a likely depressive 
disorder was 68%, n=17 (Table 4). Among those without 
a likely depressive disorder, the prevalence of  suicidal 
ideation was 8% (95% CI: 5%, 13%), n=15. In bivariable 
log binomial regression (Table 5), marital status (β= -0.53, 
95% CI: -1.76, 0.69, p value=0.40), ART use (β= 0.48, 95% 
CI: -0.51, 1.47, p value=0.43) and HIV disclosure (β= 0.87, 
95% CI: -0.49, 2.22, p value=0.21) were not associated with 
Table 2: Prevalence of depression and suicidal ideation by ART use 
among people living with HIV receiving HIV care in Lilongwe, 
Malawi (July to September 2013); N=206
Table 3: Bivariable results for factors associated with depression 
severity (continuous PHQ-9 score) among people living with HIV 
receiving HIV care in Lilongwe, Malawi (July to September 2013); 
N=206
Table 4: Prevalence of suicidal ideation by depression among 
people living with HIV receiving HIV care in Lilongwe, Malawi, 
July to September 2013; N=206
Malawi Medical Journal 30 (4);236-242 December 2018 Depression and suicidal ideation among HIV patients    240
https://dx.doi.org/10.4314/mmj.v30i4.5
suicidal ideation among those without a likely depressive 
disorder. While, having no primary, secondary, or tertiary 
education (β= -1.52, 95% CI: -2.46, -0.59, p value<0.01) was 
significantly associated with suicidal ideation among those 
without a likely depressive disorder.
Coefficient 95% CI p-value
Marital status











     Pre-ART 0.48 (-0.51, 1.47) 0.43




No 0.87 (-0.49, 2.22) 0.21
Discussion
This study was one of  the first to assess the prevalence of  
depression and suicidal ideation using a brief  depression 
screening tool within an HIV clinic population in Malawi. 
In this sample of  HIV clinic patients either pre-ART or on 
established ART in Malawi, approximately one in ten had a 
likely depressive disorder, according to the PHQ-9. Suicidal 
ideation prevalence was nearly 20% with a noticeable 
proportion of  patients with suicidal ideation that were likely 
not depressed according to the PHQ-9.  Problematic alcohol 
use was statistically significantly associated with greater 
depression severity. ART adherence, ascertained through 
self-reported pill count, was not associated with depression 
score.
The likely depressive disorder prevalence within our 
sample of  PLHIV is comparable with prevalence estimates 
from other settings in sub-Saharan Africa1. The pooled 
prevalence of  major depression diagnosed by diagnostic 
interviews was 18%1. Among PLHIV in rural HIV clinics 
of  Mzuzu, Malawi, the prevalence of  psychological distress, 
including depression, determined using the Self  Reporting 
Questionnaire (SRQ) was 14%34. The variation between our 
depression prevalence and others is likely due to the variety 
of  diagnostic interviews or depression screening tools 
used, some of  which have not been validated. The PHQ-9, 
which was used within this study, has not specifically been 
validated within Malawi, however, it has good sensitivity 
and specificity for depression among PLHIV in other SSA 
settings, supporting the use within this context24,25. Also, it 
is important to note that the interviewer assisted screening 
of  depression may lead to the underreporting of  depressive 
symptoms. The high prevalence of  likely depressive disorder 
emphasizes the importance of  depression screening among 
PLHIV receiving HIV care. Surprisingly, the prevalence 
of  suicidal ideation was higher than the overall depression 
prevalence within this sample, which was contrary to 
previous findings in Malawi. This result was unexpected 
given individuals with active suicidal thoughts generally 
also have a likely depressive disorder20. Suicidal ideation 
has also been previously associated with recent diagnosis30. 
Within our sample, suicidal ideation was not correlated with 
pre-ART patients, who likely had a recent HIV diagnosis. 
Improvements in access to ART and health outcomes among 
PLHIV in Malawi may explain this lack of  association35,36. 
Nonetheless, a deeper understanding is strongly needed of  
the underlying pathways for the presence of  suicidal ideation 
among those without likely depressive disorder.
Depression has consistently been linked with higher rates of  
heavy drinking and alcohol use disorders among PLHIV37,38. 
Within our sample, more problematic alcohol use was 
strongly associated with likely depressive disorder. Due to 
the cross-sectional nature of  this study, we were unable to 
determine the temporal order of  alcohol use and depression. 
Nonetheless, the risk factors for problematic alcohol use can 
be driven by depressive symptoms and when undiagnosed 
and untreated, depression likely leads to increased alcohol use 
over time39-41.  The co-occurring conditions of  depression 
and problematic alcohol use among PLHIV is particularly 
concerning given the adverse effects on health and treatment 
outcomes, such as poor ART adherence and greater HIV 
disease progression1,7. Alcohol reduction interventions 
including brief  interventions, social skills training, and 
reinforcement approach are effective and should be explored 
among PLHIV within resource limited settings42. Likely 
depressive disorders should be identified and treated to also 
potentially reduce problematic alcohol use.
Among our sample, ART adherence was not associated with 
likely depressive disorder. It has been widely documented 
that depression leads to poor ART adherence1,2,43. Our 
lack of  association may be explained by our self-reported 
measurement of  ART adherence, which relies on the veracity 
of  the patients’ reports. Future studies should incorporate 
validated ART adherence measurements to enhance the 
understanding of  ART adherence and depression among 
PLHIV in Malawi. Furthermore, our sample was among a 
small sample of  those receiving care at an HIV clinic within 
Lilongwe. A larger sample among those receiving HIV 
care and not receiving HIV care would not only be more 
representative of  PLHIV in Malawi, but would also capture 
those with depression that are not engaged in HIV care and 
therefore, not ART adherent. The cross-sectional nature of  
our study does not allow for the assessment of  temporality of  
the factors associated with depression and suicidal ideation. 
Although our study had relatively small sample size, we were 
able to explore the prevalence and correlates with depression 
and suicidal ideation using bivariable analyses. Future 
prospective, appropriately powered studies will enhance our 
findings. 
Conclusions
Overall, our study presents important data on factors that 
could predict depression and suicidal ideation among PLHIV 
in Malawi.  These findings highlight the need to screen for 
depression and suicidal ideation among PLHIV in Malawi. 
Table 5: A prior set of factors associated with suicidality among 
people without depression (PHQ-9 score <10) and living with 
HIV receiving HIV care in Lilongwe, Malawi (July to September 
2013); N= 181
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If  left undiagnosed and untreated, PLHIV with depressive 
disorders and suicidal ideation may engage in sexual risk 
behaviours potentially placing HIV-uninfected sexual 
partners at risk for HIV acquisition. Future interventions 
should be developed to support HIV care clinicians in the 
identification and management of  depression in high HIV 
prevalence settings.  
Acknowledgements 
This work was supported by the Fogarty International 
Center in the National Institutes of  Health under the AIDS 
International Training Research Program (AITRP), grant 
(5D43 TW001039), the UNC Hopkins Morehouse Tulane 
Fogarty Global Health Fellows Program (R25 TW009340), 
and the National Institute of  Mental Health training grant 
(5T32 AI070114).
References
1. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, 
Ram M, et al. Depression, alcohol use and adherence to antiretroviral 
therapy in sub-Saharan Africa: a systematic review. AIDS Behav. 
2012;16(8):2101-2118. doi: 10.1007/s10461-011-0087-8
2. Sikkema KJ, Watt MH, Drabkin AS, Meade CS, Hansen NB, Pence 
BW. Mental health treatment to reduce HIV transmission risk behavior: 
a positive prevention model. AIDS Behav. 2010;14(2):252-262. doi: 
10.1007/s10461-009-9650-y
3. Smit J, Myer L, Middelkoop K, Seedat S, Wood R, Bekker LG, 
et al. Mental health and sexual risk behaviours in a South African 
township: a community-based cross-sectional study. Public Health. 
2006;120(6):534-542. doi: 10.1016/j.puhe.2006.01.009
4. Olley BO, Seedat S, Stein DJ. Persistence of psychiatric disorders 
in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-
up study. J Psychosom Res. 2006;61(4):479-484. doi: 10.1016/j.
jpsychores.2006.03.010
5. Meade CS, Sikkema KJ. HIV risk behavior among adults with severe 
mental illness: a systematic review. Clin Psychol Rev. 2005;25(4):433-
457. doi: 10.1016/j.cpr.2005.02.001
6. Lundberg P, Rukundo G, Ashaba S, Thorson A, Allebeck P, 
Östergrenet P-O, et al. Poor mental health and sexual risk behaviours in 
Uganda: a cross-sectional population-based study. BMC Public Health. 
2011;11:125. https://doi.org/10.1186/1471-2458-11-125
7. Collins PY, Holman AR, Freeman MC, Patel V. What is the relevance 
of mental health to HIV/AIDS care and treatment programs in 
developing countries? A systematic review. AIDS. 2006;20(12):1571-
1582. doi: 10.1097/01.aids.0000238402.70379.d4
8. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman 
P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive 
symptoms among HIV-seropositive women: longitudinal analysis from 
the HIV Epidemiology Research Study. JAMA. 2001;285(11):1466-
1474. doi:10.1001/jama.285.11.1466
9. Leserman J, Pence BW, Whetten K, Mugavero MJ, Thielman NM, 
Swartz MS, et al. Relation of lifetime trauma and depressive symptoms 
to mortality in HIV. Am J Psychiatry. 2007;164(11):1707-1713. doi: 
10.1176/appi.ajp.2007.06111775
10. Pence BW, Miller WC, Gaynes BN, Eron JJ, Jr. Psychiatric illness 
and virologic response in patients initiating highly active antiretroviral 
therapy. J Acquir Immune Defic Syndr. 2007;44(2):159-166. doi: 
10.1097/QAI.0b013e31802c2f51
11. Nakimuli-Mpungu E, Musisi S, Katabira E, Nachega J, Bass J. 
Prevalence and factors associated with depressive disorders in an 
HIV+ rural patient population in southern Uganda. J Affect Disord. 
2011;135(1-3):160-167. doi: 10.1016/j.jad.2011.07.009
12. Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons 
newly diagnosed with HIV infection are at high risk for depression 
and poor linkage to care: results from the Steps Study. AIDS Behav. 
2011;15(6):1161-1170. doi:  10.1007/s10461-010-9778-9
13. Mugavero M, Ostermann J, Whetten K, Leserman J, Swartz M, 
Stangl D, et al. Barriers to antiretroviral adherence: the importance 
of depression, abuse, and other traumatic events. AIDS Patient Care 
STDS. 2006;20(6):418-428. doi: 10.1089/apc.2006.20.418
14. Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga GI, Fawzi 
WW, et al. Depressive symptoms increase risk of HIV disease progression 
and mortality among women in Tanzania. J Acquir Immune Defic 
Syndr. 2007;44(4):470-477. doi: 10.1097/QAI.0b013e31802f1318
15. Freeman M, Patel V, Collins PY, Bertolote J. Integrating mental 
health in global initiatives for HIV/AIDS. Br J Psychiatry. 2005;187:1-
3. doi: 10.1192/bjp.187.1.1
16. World Health Organization. mhGAP : Mental Health Gap Action 
Programme : scaling up care for mental, neurological and substance 
use disorders. Geneva, Switzerland: World Health Organization;2008.
17. Udedi M. The prevalence of depression among patients and its 
detection by primary health care workers at Matawale Health Centre 
(Zomba). Malawi Med J. 2014;26(2):34-37.
18. National Statistical Office (NSO) [Malawi] and ICF. Malawi 
Demographic and Health Survey 2015-16. Zomba, Malawi, and 
Rockville, Maryland, USA. NSO and ICF2017.
19. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses 
in 3275 suicides: a meta-analysis. BMC Psychiatry. 2004;4:37. doi: 
10.1186/1471-244X-4-37
20. Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM. Psychological 
autopsy studies of suicide: a systematic review. Psychol Med. 
2003;33(3):395-405.
21. Pence BW, Gaynes BN, Atashili J, O’Donnell JK, Kats D, Whetten 
K, et al. Feasibility, Safety, Acceptability, and Preliminary Efficacy of 
Measurement-Based Care Depression Treatment for HIV Patients in 
Bamenda, Cameroon. AIDS Behav. 2014. 18(6):1142-51. doi: 10.1007/
s10461-014-0727-x
22. Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V. The prevalence 
and characteristics of suicidality in HIV/AIDS as seen in an African 
population in Entebbe district, Uganda. BMC Psychiatry. 2012;12:63. 
doi:  10.1186/1471-244X-12-63
23. American Psychiatric Association. Diagnostic and Statistical 
Manual of Mental Disorders, 4th ed. Washington, DC2000.
24. Pence BW, Gaynes BN, Atashili J, O’Donnell JK, Tayong G, 
Kats D, et al. Validity of an interviewer-administered patient health 
questionnaire-9 to screen for depression in HIV-infected patients in 
Cameroon. J Affect Disord. 2012;143(1):208-213. doi: 10.1016/j.
jad.2012.05.056
25. Cholera R, Gaynes BN, Pence BW, Bassett J, Qangule N, Macphail 
C, et al. Validity of the Patient Health Questionnaire-9 to screen 
for depression in a high-HIV burden primary healthcare clinic in 
Johannesburg, South Africa. J Affect Disord. 2014;167:160-166. doi: 
10.1016/j.jad.2014.06.003
26. Monahan PO, Shacham E, Reece M, Kroenke K, Ong’or WO, 
Omollo O, et al. Validity/reliability of PHQ-9 and PHQ-2 depression 
scales among adults living with HIV/AIDS in western Kenya. J Gen 
Intern Med. 2009;24(2):189-197. doi: 10.1007/s11606-008-0846-z
27. Pinto-Meza A, Serrano-Blanco A, Penarrubia MT, Blanco E, Haro 
JM. Assessing depression in primary care with the PHQ-9: can it be 
carried out over the telephone? J Gen Intern Med. 2005;20(8):738-742. 
doi: 10.1111/j.1525-1497.2005.0144.x
28. Havlik RJ, Brennan M, Karpiak SE. Comorbidities and depression 
in older adults with HIV. Sex Health. 2011;8(4):551-559. doi: 10.1071/
SH11017
29. Shacham E, Small E, Onen N, Stamm K, Overton ET. Serostatus 
Malawi Medical Journal 30 (4);236-242 December 2018 Depression and suicidal ideation among HIV patients    242
https://dx.doi.org/10.4314/mmj.v30i4.5
disclosure among adults with HIV in the era of HIV therapy. AIDS 
Patient Care STDS. 2012;26(1):29-35. doi: 10.1089/apc.2011.0183
30. Gielen AC, McDonnell KA, O’Campo PJ, Burke JG. Suicide 
risk and mental health indicators: Do they differ by abuse and HIV 
status? Women’s Health Issues. 2005;15(2):89-95. doi: https://doi.
org/10.1016/j.whi.2004.12.004
31. McManus H, Petoumenos K, Franic T, Kelly MD, Watson J, et al. 
Determinants of suicide and accidental or violent death in the Australian 
HIV Observational Database. PLoS ONE 9(2): e89089. doi:10.1371/
journal.pone.0089089
32. Ogundipe OA, Olagunju AT, Adeyemi JD. Suicidal ideation 
among attendees of a West African HIV clinic. Arch Suicide Res. 
2015;19(1):103-116. doi: 10.1080/13811118.2014.915776
33. Govender RD, Schlebusch L. Suicidal ideation in seropositive 
patients seen at a South African HIV voluntary counselling and testing 
clinic. Afr J Psychiatry (Johannesbg). 2012;15(2):94-98. doi: http://
dx.doi.org/10.4314/ajpsy.v15i2.12
34. Mwale CM. The prevalence of psychological distress and associated 
factors among people  living with aids attending antiretroviral therapy 
clinics in Mzuzu, Malawi:  A cross sectional descriptive study 
[dissertation]. Malawi: College of Medicine, University of Malawi; 
2006.
35. Malawi Ministry of Health. Clinical Management of HIV in 
Children and Adults. Department for HIV and AIDS of the Ministry of 
Health;2014.
36. Herce ME, Mtande T, Chimbwandira F, Mofolon I, Chingondole 
CK, Rosenberg NE, et al. Supporting Option B+ scale up and 
strengthening the prevention of mother-to-child transmission cascade in 
central Malawi: results from a serial cross-sectional study. BMC Infect 
Dis. 2015;15:328. https://doi.org/10.1186/s12879-015-1065-y 
37. Palfai TP, Cheng DM, Coleman SM, Bridden C, Krupitsky E, Samet 
JH. The influence of depressive symptoms on alcohol use among HIV-
infected Russian drinkers. Drug Alcohol Depend. 2014;134:85-91. doi: 
10.1016/j.drugalcdep.2013.09.014
38. Farley J, Miller E, Zamani A, Tepper V, Morris C, Oyegunle M, et 
al. Screening for hazardous alcohol use and depressive symptomatology 
among HIV-infected patients in Nigeria: prevalence, predictors, and 
association with adherence. J Int Assoc Physicians AIDS Care (Chic). 
2010;9(4):218-226. doi: 10.1177/1545109710371133
39. Holahan CJ, Moos RH, Holahan CK, Cronkite RC, Randall PK. 
Unipolar depression, life context vulnerabilities, and drinking to cope. 
J Consult Clin Psychol. 2004;72(2):269-275. doi: 10.1037/0022-
006X.72.2.269
40. McKellar J, Ilgen M, Moos BS, Moos R. Predictors of changes 
in alcohol-related self-efficacy over 16 years. J Subst Abuse Treat . 
2008;35(2):148-155. doi: 10.1016/j.jsat.2007.09.003
41. Ralston TE, Palfai TP. Depressive symptoms and the implicit 
evaluation of alcohol: the moderating role of coping motives. 
Drug Alcohol Depend. 2012;122(1-2):149-151. doi: 10.1016/j.
drugalcdep.2011.09.011
42. Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis 
of clinical trials of treatments for alcohol use disorders. Addiction 
(Abingdon, England). 2002;97(3):265-277.
43. Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression 
and HIV/AIDS treatment nonadherence: a review and meta-analysis. 
J Acquir Immune Defic Syndr. 2011;58(2):181-187. doi:  10.1097/
QAI.0b013e31822d490a
 
